Esperion Therapeutics, Inc (NASDAQ: ESPR ) has been running a gauntlet of biotech and healthcare conferences over the past several weeks. The stock has actually responded positively. Still, while it is nice to see a timely 64% rebound off the all-time lowDr. Duru has blogged about financial markets since the year 2000. A veteran of the dot-com bubble and bust, the financial crisis, and the coronavirus pandemic, he fully appreciates the value in trading and investing around the extremes of market behavior. I ...